• Cynata Therapeutics talks 18th annual Bioshares Biotech Summit

  • Jul 17 2024
  • Duración: 6 m
  • Podcast

Cynata Therapeutics talks 18th annual Bioshares Biotech Summit Por arte de portada

Cynata Therapeutics talks 18th annual Bioshares Biotech Summit

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • Cynata Therapeutics Ltd (ASX:CYP) CEO and managing director Dr Kilian Kelly is in the Proactive studio following the 18th annual Bioshares Biotech Summit in Perth. Cynata is an Australian stem cell and regenerative medicine company that is developing a therapeutic stem cell platform technology, Cymerus™, using discoveries made at the University of Wisconsin-Madison (UWM). UWM is a world-renowned leader in stem cell research, in particular for the work by Professor James Thomson’s group, which included the first successful isolation of human embryonic stem cells in 1998 and the derivation of induced pluripotent stem cells (iPSCs) from human adult cells in 2007. Professor Igor Slukvin, a co-founder of Cynata, was also a member of the team that conducted UWM’s pioneering iPSC research. The Cymerus technology has several characteristics which makes it ideal for the development of cell-based therapeutics. Most critically, the Cymerus manufacturing process ensures that cells for therapeutic use can be produced in virtually limitless quantities. This means that Cynata will not have to constantly seek out fresh stem cell donors to fuel its manufacturing demands. This has the potential to create a new standard in the emergent arena of regenerative medicine and stem cell therapeutics and provides Cynata with both a unique differentiator and an important competitive position. #ProactiveInvestors #CynataTherapeutics #ASX #CYP #Biotech #Bioshares #Summit #BiosharesBiotechSummit #StemCell #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    Más Menos
activate_primeday_promo_in_buybox_DT
Empresas y Profesiones Economía Finanzas Personales Política y Gobierno
Más Menos

Lo que los oyentes dicen sobre Cynata Therapeutics talks 18th annual Bioshares Biotech Summit

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles